Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:55 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2425–2448 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Premature Birth
Interventions: Prophylactic Delivery Room Continuous Positive Airway Pressure; Procedure
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Minute to 5 Minutes
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Indianapolis, Indiana • St Louis, Missouri • Oklahoma City, Oklahoma

Conditions: Systolic Heart Failure, Heart Failure With Reduced Ejection Fraction, CRT Non-Response, Left Bundle Branch Area Pacing
Interventions: Left bundle branch area pacing, Cardiac MRI; Device · Diagnostic Test
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cryptosporidiosis, HIV Infections
Interventions: Paromomycin sulfate; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1996
U.S. locations: 14
States / cities: Los Angeles, California • Miami, Florida • Chicago, Illinois + 7 more

Conditions: Contraception, Contraception Behavior
Interventions: Intervention Group, Control Group; Diagnostic Test · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 21 Years · Female only
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Mathematics Abilities
Interventions: Book Reading Intervention; Behavioral
Lead sponsor: University of Dayton; Other
Eligibility: 3 Years to 5 Years
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Dayton, Ohio

Conditions: Panic Disorder
Interventions: Cognitive behavioral therapy, D-cycloserine; Behavioral · Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 2
States / cities: Hartford, Connecticut • Boston, Massachusetts

Conditions: Coronary Disease, Coronary Artery Disease, Coronary Restenosis
Interventions: ZoMaxx™ Drug-Eluting Coronary Stent System, TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,099 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 74
States / cities: Huntsville, Alabama • Gilbert, Arizona • La Jolla, California + 60 more

Conditions: Uterine Fibroids
Interventions: MR Guided Focused Ultrasound, Placebo MR Guided Focused Ultrasound; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Autism, Autism Spectrum Disorder, ASD
Interventions: Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C), Home-Based Pivotal Response Treatment (PRT Intervention (PRT-H); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 5 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Preterm Birth, Health Care Utilization, Tobacco Use, Contraceptive Usage, Depression, Weight, Birth
Interventions: Care Coordination after Preterm Birth (CCAPB); Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 14 Years to 45 Years · Female only
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Depression, HIV
Interventions: Beating the Blues; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Deep Full-thickness Burn Injury (Disorder)
Interventions: realSKIN (skin xenotransplant), Human Cadaver Allograft; Biological
Lead sponsor: XenoTherapeutics, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Augusta, Georgia • Boston, Massachusetts

Conditions: HIV Infections
Interventions: HIV-1 gag DNA (formulated with bupivacaine), IL-15 DNA (formulated with bupivacaine), IL-12 DNA (formulated with bupivacaine), Sodium chloride injection USP (0.9%); Biological
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 6
States / cities: Birmingham, Alabama • Denver, Colorado • Orlando, Florida + 3 more

Conditions: Nausea and Vomiting, Nausea, Vomiting
Interventions: Fosaprepitant 150 mg, Ondansetron 4 mg; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Transient Tachypnea
Interventions: Prophylactic CPAP Administration; Other
Lead sponsor: New York Hospital Queens; Other
Eligibility: 2 Minutes to 30 Minutes
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Flushing, New York

Conditions: Plantar Fascitis, Fat Pad Syndrome
Interventions: PopSole™ offloading device, padded insole; Device
Lead sponsor: Jeffrey A. Gusenoff, MD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Diabetic Foot Ulcer
Interventions: Affinity human amniotic membrane; Other
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 6
States / cities: Miami Lakes, Florida • North Miami Beach, Florida • Ford City, Pennsylvania + 3 more

Conditions: Oppositional Defiant Disorder, Oppositional Defiant Disorder in Children
Interventions: Regulation Focused Psychotherapy for Children; Behavioral
Lead sponsor: Yeshiva University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Stroke, Social Determinants of Health
Interventions: SHIFT team intervention; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Foot Ulcer, Diabetic
Interventions: MatriStem, Cellular Dermal Replacement Tissue; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 9
States / cities: Phoenix, Arizona • Castro Valley, California • Fresno, California + 5 more

Conditions: Head Lice, Pediculosis Capitis
Interventions: X92001752, RID Super Max Solution, Nix Crème, Pouxit Végétal; Device · Drug
Lead sponsor: Oystershell NV; Industry
Eligibility: 1 Year and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Plantation, Florida

Conditions: Transfemoral Amputation, Amputation, Skin Health
Interventions: AeroFit Seal-In Liner / Socket, Seal-In Silicone Liner; Device
Lead sponsor: Össur Iceland ehf; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 7
States / cities: Gainesville, Florida • Indianapolis, Indiana • Bay City, Michigan + 3 more

Conditions: Chalazion, Dry Eye Syndromes
Interventions: Manual Mini System, iHeat Portable Warm Compress Therapy; Device
Lead sponsor: TearScience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 11
States / cities: Fayetteville, Arkansas • Morrow, Georgia • Highland Park, Illinois + 8 more

Conditions: Optic Neuritis
Interventions: Clemastine, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 55 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT

Evaluation of Left Bundle Branch Area Pacing As A Rescue Strategy for Cardiac Resynchronization Therapy Non-Response

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Contraception Initiation Feasibility in the Pediatric ED

Flexible Attention to Magnitudes and Early Math

Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries

Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids

Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

Health and Wellness After Preterm Birth

Depression Therapy to Improve Cardiovascular Risk in HIV

Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds

Study Evaluating Vaccine in Adults With HIV

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial

Offloading Device for Post Surgical Foot Procedures

Affinity Prospective Diabetic Foot Trial Crossover Group

Evaluation of Regulation Focused Psychotherapy for Children

SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes

A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers

A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product.

Aerofit Post Market Investigation

Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)